Comprehensive Income (MB.) 2021 (01/01/21 -31/12/21) 2020 (01/01/20 -31/12/20) 2019 (01/01/19 -31/12/19) 2018 (01/01/18 -31/12/18) Accounting Type Consolidate Consolidate Consolidate Consolidate
) Reports on Acquisition or Disposition of Securities (246-2) Financial Statements (Concise Version) 5/ Full Version Statement of Comprehensive Income (MB.) 2021 (01/01/21 -31/12/21) 2020 (01/01/20 -31
of Securities (246-2) Financial Statements (Concise Version) 5/ Full Version Statement of Comprehensive Income (MB.) 2021 (01/01/21 -31/12/21) 2020 (01/01/20 -31/12/20) 2019 (01/01/19 -31/12/19
) Reports on Acquisition or Disposition of Securities (246-2) Financial Statements (Concise Version) 5/ Full Version Statement of Comprehensive Income (MB.) 9M/2022 (01/04/21 -31/12/21) 9M/2021 (01/04/20
(times) 1.35 0.66 0.65 +68bps +70bps * ‘Integrated Oxides and Derivatives’ was previously called Olefins. The new nomenclature better reflects our sector following the consolidation of Huntsman assets
(5%) 5% 8,405 11,014 30% Selling and administrative expenses (606) (418) (437) (28%) 4% (975) (855) (12%) Other operating income 3 5 5 84% 0% 5 10 87% EBITDA 5,324 4,951 5,218 (2%) 5% 7,436 10,169 37
Page 2 of 7 Total revenue of Q3/2018 of the Group was Bt940.5 million increased by Bt54.4 million or 6.1% compared with Bt886.1 million of Q3/2017. While the services income was Bt928.9 million increased
to dialysate unit business - one of the Company’s core businesses. This is expected to generate income and profit to the Company, then, makes the Company gain much more improved financial position and